The transition to digital in healthcare is happening at a fast pace.
It is the pot of gold at the end of the medical rainbow—the promise that, by harnessing data, researchers can tailor drugs, devices, and treatments to the genetic configuration, lifestyle, and environment of individual patients.
As medical devices using software and wireless communication become more ubiquitous, hackers are becoming more advanced in their methods.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.
Health technology developers need to prioritize security from the moment a device or platform is first incepted.
Having an effective business continuity management system based on ISO 22301 can help medtech companies remain resilient.
For reliable systems, we need a different mindset.
Long-term industry efforts are essential in closing the gaps in the device ecosystem.
It’s no longer science fiction.
Pharmaceutical companies have long been subject to the kinds of rigorous electronic reporting standards that will soon affect medical device manufacturers. What can be gleaned from their experiences?